UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT ~~PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934~~

~~Date~~Pursuant ofto ~~Report~~Section 13 OR 15(~~Date~~d) ofOf ~~earliest~~The Securities ~~event~~Exchange ~~reported): January~~Act ~~31,~~Of ~~2014~~1934

~~ALPHALA~~Date ~~CORP.~~ of Report (Date of earliest event reported): July 10, 2014

FV Pharma International Corp.

(Exact name of registrant as specified in its charter)

Nevada		333-187669		68-0682594
(State or other jurisdiction of incorporation)		(Commission File Number)		(I.R.S. Employer Identification No.)

203 -– 29 Gervais Drive

Toronto, Ontario, Canada M3C 1Y9

(Address of principal executive offices and zip code)

(416) 444-4427
(Registrant’s telephone number, including area code)

~~Darzinu~~Alphala 22Corp. (Former ~~linija~~name, 10former ~~Majas~~address and former fiscal year, if changed since last report)

Riga, Latvia LV-1063 (Former name, former address and former fiscal year, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

~~[ ]~~¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

~~[ ]~~¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)

~~[ ]~~¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))

~~[ ]~~¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))

Item 5.0103 ~~Changes~~Amendments into ~~Control~~Articles of ~~Registrant~~Incorporation of Bylaws; Change in Fiscal Year

~~Item~~On 5July 10, 2014, Alphala Corp.02 ~~Departure~~(the of“Company”) filed ~~Directors~~a orCertificate ~~Certain~~of ~~Officers;~~Amendment ~~Election~~to its Articles of ~~Directors;~~Incorporation ~~Appointment~~(the “Amendment”) with the State of ~~Certain~~Nevada ~~Officers;~~to ~~Compensatory~~change its ~~Arrangements~~corporate name from “Alphala Corp” to “FV Pharma International Corp.” A copy of ~~Certain~~the ~~Officers~~Amendment is attached to this Current Report on Form 8-K as Exhibit 3.1.

OnThe ~~January~~Company ~~31,~~informed ~~2014,~~the ~~Shaikh~~Financial ~~M. Shami acquired~~Industry ~~6,000,000~~Regulatory ~~shares,~~Authority or(“FINRA”) ~~approximately~~of ~~71.77%~~such ofcorporate ~~the~~name ~~issued~~change and ~~outstanding~~requested ~~common~~a ~~stock~~symbol ~~(the~~change from “~~Shares~~ALPC”~~) of Alphala Corp.~~ ~~(the~~to “~~Corporation~~FVPI”), ~~from~~corresponding ~~Irina~~to ~~Petrzhikovskaya,~~ the ~~Corporation’s~~corporate ~~former~~name ~~sole~~change. ~~officer~~On ~~and~~August ~~director~~5, ~~for the purchase price of $120~~2014,~~000.~~ ~~The~~FINRA ~~acquisition~~announced ~~was governed by~~ the ~~terms~~corporate ofname achange and ~~stock~~symbol ~~purchase~~change ~~agreement~~and ~~between~~both ~~Mr.~~corporate ~~Shami~~actions ~~and~~took ~~Ms.~~effect ~~Petrzhikovskaya dated~~on ~~January~~August 226, 2014 ~~(the “Stock Purchase Agreement”)~~. ~~Mr. Shami paid the purchase price for the Shares in cash from his personal funds.~~

~~There~~Item ~~are~~9.01 noFinancial ~~arrangements~~Statements ~~known~~and ~~to the Corporation the operation of which may, at a subsequent date, result in a change in control.~~Exhibits

~~There~~(d) are no arrangements or understandings among Mr. Shami and Ms. Petrzhikovskaya, or their respective associates, with respect to the election of directors of the Corporation or other matters, except that at the closing of the Stock Purchase Agreement the Corporation increased the number of directors on its Board of Directors to two and appointed Mr. Shami to fill the resulting vacancy until his successor is duly elected and qualified. Promptly thereafter, Ms. Petrzhikovskaya resigned as a director of the Corporation and, as a result, Mr. Shami is currently its sole director.Exhibits

Also at the closing of the Stock Purchase Agreement, Ms. Petrzhikovskaya resigned from all of her officer positions and the Corporation appointed Mr. Shami as its President, Chief Executive Officer, Chief Financial Officer, Chief Accounting Officer, Secretary and Treasurer, to serve as such until his successors are duly elected and qualified.

Exhibit No.		Description

3.1		Certificate of Amendment

Mr. Shami, age 45, has occupied senior executive roles in a number of different telecommunications companies over the past dozen years. He has served as the President, Chief Executive Officer and a director of Kimcot Inc., a Toronto, Ontario-based firm since 2001, and has also acted as the same capacities for 3MW Ltd. and Travellers Emergency Hotline (TEH) since 2011 and 2012, respectively. Both Kimcot and 3MW operate multiple retail units on behalf of large, national telecommuncations carriers in Canada, while TEH is an around-the-clock emergency travel services provider catering primarily to business clients that handles calls for the eastern Canadian division of Uniglobe Travel, among other organizations.SIGNATURES

~~Mr.~~Pursuant ~~Shami~~to ~~holds~~the ~~MCSE~~requirements ~~(Microsoft~~of ~~Certified~~the Securities ~~Systems~~Exchange ~~Engineer)~~Act ~~and~~of ~~MCP (Microsoft Certified Professional) designations~~1934, ~~and~~the isregistrant ~~also~~has aduly ~~Cisco~~caused ~~Certified~~this ~~Network~~report ~~Associate (CCNA).~~to Hebe ~~received~~signed aon ~~Bachelor~~its ofbehalf ~~Arts~~by ~~from~~the ~~Punjab~~undersigned ~~University~~hereunto induly ~~Lahore, Pakistan~~authorized.

Mr. Shami has experience with several start-up enterprises in the operational management, strategic planning, customer service and business development fields, and his multiple-industry background as well as his telecommunications-specific qualifications and skills and the led to the conclusion that he should serve as a director of the Corporation.

Date: August 12, 2014	FV Pharma International Corp.

	By:	/s/ Shaikh M. Shami
		Shaikh M. Shami
		President, Chief Executive Officer, Chief Financial Officer and Chief Accounting Officer,

There are no family relationships between Mr. Shami and Ms. Petrzhikovskaya, the former sole officer and director of the Corporation. The Corporation has not entered into any material plan, contract or arrangement with Mr. Shami relating to his services as an officer or director.

Other than as disclosed above, during the past five years none of the officers or directors of the Corporation has been a director of any company with a class of securities registered pursuant to section 12 of the Exchange Act or subject to the requirements of section 15(d) of the Exchange Act, or any company registered as an investment company under the Investment Company Act of 1940.

There have been no other transactions since the beginning of the Corporation’s last fiscal year or any currently proposed transactions in which the Corporation is, or plans to be, a participant and the amount involved exceeds the lesser of $120,000 or 1% of the average of its total assets for the last two completed fiscal years, and in which any related person had or will have a direct or indirect material interest.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: February 7, 2014	Alphala Corp.
	By:	/s/ Shaikh M. Shami
		Shaikh M. Shami
		President, Chief Executive Officer, Chief Financial Officer, Chief Accounting Officer, Secretary, Treasurer, Director

Filing Compare · FV Pharma International Corp.